Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death

被引:229
作者
Wiekowski, MT
Leach, MW
Evans, EW
Sullivan, L
Chen, SC
Vassileva, G
Bazan, JF
Gorman, DM
Kastelein, RA
Narula, S
Lira, SA
机构
[1] Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Drug Safety & Metab, Lafayette, NJ 07848 USA
[3] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
关键词
D O I
10.4049/jimmunol.166.12.7563
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
p19, a molecule structurally related to IL-6, G-CSF, and the p35 subunit of IL-12, is a subunit of the recently discovered cytokine IL-23. Here we show that expression of p19 in multiple tissues of transgenic mice induced a striking phenotype characterized by runting, systemic inflammation, infertility, and death before 3 mo of age. Founder animals had infiltrates of lymphocytes and macrophages in skin, lung, liver, pancreas, and the digestive tract and were anemic. The serum concentrations of the proinflammatory cytokines TNF-alpha and IL-1 were elevated, and the number of circulating neutrophils was increased. In addition, ubiquitous expression of p19 resulted in constitutive expression of acute phase proteins in the liver. Surprisingly, liver-specific expression of p19 failed to reproduce any of these abnormalities, suggesting specific requirements for production of biologically active p19. Bone marrow transfer experiments showed that expression of p19 by hemopoietic cells alone recapitulated the phenotype induced by its widespread expression, pointing to hemopoietic cells as the source of biologically active p19. These findings indicate that p19 shares biological properties with IL-6, IL-12, and G-CSF and that cell-specific expression is required for its biological activity.
引用
收藏
页码:7563 / 7570
页数:8
相关论文
共 40 条
  • [11] Signaling through gp130: Toward a general scenario of cytokine action
    Fukada, T
    Yoshida, Y
    Nishida, K
    Ohtani, T
    Shirogane, T
    Hibi, M
    Hirano, T
    [J]. GROWTH FACTORS, 1999, 17 (02) : 81 - 91
  • [12] Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: Roles in inflammation and injury
    Gadient, RA
    Patterson, PH
    [J]. STEM CELLS, 1999, 17 (03) : 127 - 137
  • [13] ADMINISTRATION OF RECOMBINANT IL-12 TO NORMAL MICE ENHANCES CYTOLYTIC LYMPHOCYTE ACTIVITY AND INDUCES PRODUCTION OF IFN-GAMMA IN-VIVO
    GATELY, MK
    WARRIER, RR
    HONASOGE, S
    CARVAJAL, DM
    FAHERTY, DA
    CONNAUGHTON, SE
    ANDERSON, TD
    SARMIENTO, U
    HUBBARD, BR
    MURPHY, M
    [J]. INTERNATIONAL IMMUNOLOGY, 1994, 6 (01) : 157 - 167
  • [14] Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
    Gay, E
    Seurin, D
    Babajko, S
    Doublier, S
    Cazillis, M
    Binoux, M
    [J]. ENDOCRINOLOGY, 1997, 138 (07) : 2937 - 2947
  • [15] INTERLEUKIN-6 IS INVOLVED IN INTERLEUKIN-1-INDUCED ACTIVITIES
    HELLE, M
    BRAKENHOFF, JPJ
    DEGROOT, ER
    AARDEN, LA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (06) : 957 - 959
  • [16] Hirano T, 1998, Int Rev Immunol, V16, P249
  • [17] HOGAN B, 1994, MANIPULATION MOUSE E
  • [18] SOMATOMEDIN-C LEVELS IN GROWTH-IMPAIRED CHILDREN AND ADOLESCENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE
    KIRSCHNER, BS
    SUTTON, MM
    [J]. GASTROENTEROLOGY, 1986, 91 (04) : 830 - 836
  • [19] DIMINISHED CONCENTRATIONS OF INSULIN-LIKE GROWTH-FACTOR-I IN CYSTIC-FIBROSIS
    LAURSEN, EM
    JUUL, A
    LANNG, S
    HOIBY, N
    KOCH, C
    MULLER, J
    SKAKKEBAEK, NE
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 72 (06) : 494 - 497
  • [20] LEE GR, 1983, SEMIN HEMATOL, V20, P61